Transgenic mice overexpressing IL-18 display increased IL-13 in the airways but no changes of the airway hyperresponsiveness in a murine model of late-phase asthma: evidence for a dual role of IL-18 on mucosal Th1/Th2 responses Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002
Antisense-induced local blockade of T-bet expression leads to airway inflammation in rats Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006
High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
Increased susceptibility to airway allergic responses in CD40 deficient mice Source: Eur Respir J 2002; 20: Suppl. 38, 567s Year: 2002
Imiquimod attenuate airway inflammation and decrease the expression of TARC in allergic asthmatic mice Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006
Decreased Smad7 expression in the airways of a mouse model of chronic asthma Source: Annual Congress 2004 - Animal models of allergic airway disease Year: 2004
Overexpression of peroxiredoxin 6 protect mice from ovalbumin-induced airway inflammation and hypersecretion of MUC5AC by reducing ROS levels Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011
Deficiency of MMP-19 promotes allergen-induced eosinophil burden and airway responsiveness in mice Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma Year: 2007
CCL6 produced by eosinophils drives allergic airway inflammation in mice Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019
AQP5 role in ovalbumin-induced airway inflammation and secretion of MUC5AC in mice Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011
Overproduction of mature IL-18 induces IL-13 producing CD4+Tcells in the lungs, and results in airway hyperresponsiveness and pulmonary inflammation in Balb/c mice Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002
Endotoxin interferes with allergy-induced airway inflammation in mice Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004
Effect of tenascin C on cytokine expression in lymphocytes from mice with allergen-induced bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 226s Year: 2006
Allergen-induced BDNF expression and neuronal remodeling contributes to airway hyperresponsiveness Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018
Development of IL-33-induced asthmatic airway inflammation in human IL-3/GM-CSF/IL-5-transgenic NOG mice Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017
Airway epithelial cell P2Y6R-Expression is up-regulated during acute and chronic allergic inflammation and contributes via modulating of CXC8 and IL-6 secretion to development of airway remodelling Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010
Estrogen protects against airway inflammation via upregulation of SLPI and downregulation of IL-33 Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
Soluble biglycan promotes ovalbumin induced airway inflammation by modulating dendritic cell function in mice Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019